Antihypertensive medication safety comparison
Pro Research Analysisby 
Searched over 200M research papers
Antihypertensive Drug Classes: Safety and Side Effect Profiles
When comparing the safety of antihypertensive medications, several major drug classes are commonly used: angiotensin-converting enzyme inhibitors (ACEIs), angiotensin receptor blockers (ARBs), beta-blockers (BBs), calcium channel blockers (CCBs), and diuretics. Research consistently shows that ARBs and CCBs are among the safest and most well-tolerated options, with ARBs in particular having a low rate of adverse drug reactions (ADRs) and a favorable risk-benefit ratio 156. CCBs, such as amlodipine, are also considered safe and effective as first-line treatments 16.
ACEIs, especially captopril and lisinopril, are generally well-tolerated but can have more significant side effects compared to other antihypertensive drugs. However, they are still recommended due to their overall safety profile and effectiveness in reducing mortality 16. Diuretics are effective and have a safety profile similar to ACEIs and ARBs, though they may be associated with a slightly higher rate of treatment discontinuation .
Beta-blockers, while effective for certain patients, tend to have a higher risk of adverse events and are less favored for first-line therapy due to a higher rate of treatment discontinuation and less favorable outcomes in some studies 36.
Efficacy and Safety in Cardiovascular Event Prevention
ACEIs, ARBs, and CCBs have all been shown to reduce the risk of major cardiovascular events compared to placebo, with diuretics showing a similar trend. Beta-blockers and renin inhibitors do not show the same level of efficacy in preventing cardiovascular events 610. In direct comparisons, ACEIs and diuretics are particularly effective in reducing myocardial infarction and revascularization, respectively .
Safety in Special Populations: Elderly and Pregnant Women
In elderly patients, intensive antihypertensive therapy reduces the risk of cardiovascular and cerebrovascular events without significantly increasing the risk of serious adverse events or all-cause mortality compared to standard therapy. However, there is a higher risk of syncope with intensive treatment .
For pregnant women with chronic hypertension, most antihypertensive agents do not significantly affect the risk of preeclampsia. However, atenolol is associated with a higher risk of small-for-gestational-age infants and is generally not recommended. Nifedipine and methyldopa are safer choices, with lower rates of severe hypertension and placental abruption .
Combination Therapy and Dosing Time
Low-dose combination therapy is increasingly used to improve blood pressure control while minimizing side effects, but comprehensive safety comparisons of different combinations are still being studied . Regarding dosing time, large studies show no significant difference in cardiovascular outcomes or safety between morning and evening dosing of antihypertensive medications. Patients can take their medications at a time that best fits their routine, as long as 24-hour blood pressure control is maintained 89.
Conclusion
Overall, ARBs and CCBs are among the safest and most acceptable antihypertensive medications, with ACEIs and diuretics also being effective and generally well-tolerated. Beta-blockers are less favored due to a higher risk of adverse events. In special populations such as the elderly and pregnant women, careful selection of agents is important to balance efficacy and safety. Combination therapy and flexible dosing times can further optimize treatment while maintaining safety 1345+5 MORE.
Sources and full results
Most relevant research papers on this topic